The Safe Fast Track Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOdense University Hospital
About this trial
Emergency departments (ED) internationally are treating an increasing number of patients.
Most require hospital services but some could be better cared for on alternative pathways.
D-dimer has some unique properties. It is non-specific and is elevated in many acute condi- tions; but conversely remains normal in the absence of significant disease. Previous studies have shown that having a normal D-dimer on arrival to the emergency department is associated with a very low risk of 30-day all-cause mortality.
The investigators propose a multicenter randomized controlled trial using D-dimer to identify patients at low risk and test if providing this information will change time to discharge disposition by the treating physician.
Eligibility criteria
Qualifiers
Age 18 or above
Able to provide oral and written informed consent in Danish
Blood tests ordered on arrival as part of standard of care
Ambulatory on arrival or walking to the ambulance (i.e., stable independent gait)
Disqualifiers
Unstable condition requiring immediate care in the resuscitation area
Triage level red (i.e., the most urgent patients)
Trauma (minor and major) patients
High likelihood of requiring a D-dimer analysis on clinical indications during the current hospital contact (e.g., suspected venous thromboembolic disease) that will be ordered on arrival regardless of this study
Trial design
Treatments tested in this trial
- D-dimer
Treatment groups
1,538 Participants
are divided into 2 treatment groupsSponsors and collaborators
Odense University Hospital
Lead sponsor
Slagelse Sygehus
Collaborator
Holbaek Sygehus
Collaborator
Esbjerg Hospital - University Hospital of Southern Denmark
Collaborator
Source ClinicalTrials.gov